FDA ephedra appeal
This article was originally published in The Tan Sheet
Executive Summary
FDA is expected to submit an opening brief in mid-August to appeal a Utah court's April decision to overturn the agency's ephedra ban. A notice of appeal was filed by FDA in 10th Circuit Court of Appeals June 13 and a court docket opened for the appeal indicates initial filings are due July 7. The Utah court ruled that plaintiff Nutraceutical Corp. could continue selling its product containing 10 mg of ephedra (1"The Tan Sheet" April 18, 2005, p. 5)...